Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 71.30 TWD
Change Today +1.80 / 2.59%
Volume 2.1M
4119 On Other Exchanges
Symbol
Exchange
Taiwan
As of 1:30 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

sci pharmtech inc (4119) Snapshot

Open
69.70
Previous Close
69.50
Day High
71.80
Day Low
69.50
52 Week High
06/16/14 - 73.81
52 Week Low
10/27/14 - 57.80
Market Cap
5.0B
Average Volume 10 Days
533.2K
EPS TTM
4.24
Shares Outstanding
69.7M
EX-Date
--
P/E TM
16.8x
Dividend
3.00
Dividend Yield
2.40%
Current Stock Chart for SCI PHARMTECH INC (4119)

Related News

No related news articles were found.

sci pharmtech inc (4119) Related Businessweek News

No Related Businessweek News Found

sci pharmtech inc (4119) Details

SCI Pharmtech, Inc. develops, produces, and sells active pharmaceutical ingredients, intermediates, and specialty chemicals in Taiwan. Its active pharmaceutical ingredients include allopurinol, amobarbital, probucol, pentobarbital sodium, thiopental, valproic acid, sodium valproate, divalproex sodium, bisoprolol hemifumarate, and propafenone products. The company also provides custom manufacturing services. The company was founded in 1987 and is based in Taoyuan, Taiwan.

Founded in 1987

sci pharmtech inc (4119) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sci pharmtech inc (4119) Key Developments

SCI Pharmtech, Inc., Q1 2015 Earnings Call, May 15, 2015

SCI Pharmtech, Inc., Q1 2015 Earnings Call, May 15, 2015

SCI Pharmtech, Inc., 2014 Operating Results Call, Mar 17, 2015

SCI Pharmtech, Inc., 2014 Operating Results Call, Mar 17, 2015

SCI Pharmtech, Inc. Proposes Amendment to Article of Incorporation

SCI Pharmtech, Inc. announced that a shareholders' meeting will be held on June 12, 2015, to consider amendment to Article of Incorporation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4119:TT 71.30 TWD +1.80

4119 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4119.
View Industry Companies
 

Industry Analysis

4119

Industry Average

Valuation 4119 Industry Range
Price/Earnings 19.3x
Price/Sales 3.2x
Price/Book 2.1x
Price/Cash Flow 16.9x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SCI PHARMTECH INC, please visit www.sci-pharmtech.com.tw. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.